Abstract
The Boston Keratoprosthesis is the most widely used artificial cornea or keratoprosthesis. It is a treatment option for corneal disease not amenable to standard penetrating keratoplasty. Continued advances in design and superior postoperative care have resulted in improved outcomes and an exponential increase in the use of the device in the last decade.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ing JJ, Ing HH, Nelson LR, et al. Ten-year postoperative results of penetrating keratoplasty. Ophthalmology. 1998;105:1855–65.
Williams KA, Ash JK, Pararajasegaram P, et al. Long-term outcome after corneal transplantation. Visual result and patient perception of success. Ophthalmology. 1991;98:651–7.
Williams KA, Muehlberg SM, Lewis RF, et al. How successful is corneal transplantation? A report from the Australian corneal graft register. Eye. 1995;9:219–27.
Price FW Jr, Whitson WE, Collins KS, et al. Five-year corneal graft survival. A large, single-center patient cohort. Arch Ophthalmol. 1993;111:799–805.
Bersudsky V, Blum-Hareuveni T, Rehany U, et al. The profile of repeated corneal transplantation. Ophthalmology. 2001;108:461–9.
Patel NP, Kim T, Rapuano CJ, et al. Indications for and outcomes of repeat penetrating keratoplasty, 1989–1995. Ophthalmology. 2000;107:719–24.
Dandona L, Naduvilath TJ, Janarthanan M, et al. Survival analysis and visual outcome in a large series of corneal transplants in India. Br J Ophthalmol. 1997;81:726–31.
Pellier de Quengsy G. Precis ou cours d’operation sur la chirurgie des yeux. Paris: Didot; 1789.
Nussbaum N. Cornea Artificialis, ein Substitut fur die Transplantatio Cornea. Deutsche Klinik. 1853;34:367.
Heusser J. Die Einheilung einer Cornea artificialis. Oesterr Ztschr Pract Med. 1860;26:424.
Dimmer F. Zwei Falle von Celluoidplattern der Hornhaut. Klin Monatsbl Augenheilkd. 1891;29:104.
Salzer F. Uber den kunstlichen Hornhautersatz. Wiesbaden; 1898.
von Hippel A. Uber die operative Behandlung totaler stationarer Hornhaut-Trubungen. Albrecht v Graefes Arch Clin Ophthal. 1887;23:79.
Verhoeff FH. Cited in Cardona H: keratoprosthesis. Am J Ophthalmol. 1962;54:284.
Filatov VP. Alloplastik bei vollstandig “hoffnungslosem” Leukomen. Soiv Viest Opht. 1936;9:400.
Wunsche G. Versuche zur totalen Keratoplastie und zur Cornea Artificialis. Arztliche Forschung. 1947;1:345.
Stone W Jr, Hebert E. Experimental study of plastic material and replacement of the cornea. Preliminary report. Am J Ophthalmol. 1953;36:168.
Castroviejo R, Cardona H, AG DV. The present status of prosthokeratoplasty. Trans Am Ophthalmol Soc. 1969;67:207–34.
Strampelli B. Osteo-Odontokeratoprosthesis. Ann Ottalmol Clin Ocul. 1963;89:1039–44.
Falcinelli G, Missiroli A, Pettiti V, et al. Osteo-Odontokeratoprosthesis up to date. In: Acta XXV Concilium Ophthalmologicum. Milano: Kugler & Ghedini; 1987.
Marchi V, Ricci R, Pecorella I, et al. Osteo-odonto-keratoprosthesis. Description of surgical technique with results in 85 patients. Cornea. 1994;13(2):125–30.
Temprano J. Resultados a largo plazo de Osteo-odonto-queratoprotesis y queratoprotesis tibial. An Inst Barraquer. 1998;27(Suppl):53–65.
Stoiber J, Csaky D, Schedle A, et al. Histopathologic findings in explanted osteo-odontokeratoprosthesis. Cornea. 2002;21(4):400–4.
Liu C, Herold J, Sciscio A, et al. Osteo-odonto-keratoprosthesis surgery. Br J Ophthalmol. 1999;83(1):127.
Hille K. Keratoprothesen. Klin Aspekt Ophthalmologe. 2002;99(7):523–31.
Pintucci S, Pintucci F, Cecconi M, et al. The Dacron felt colonizable keratoprosthesis: after 15 years. Eur J Ophthalmol. 1996;6(2):125–30.
Girard LJ, Hawkins RS, Nieves R, et al. Keratoprosthesis: a 12-year follow-up. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1977;83(2):252–67.
Legeais JM, Renard G, Parel JM, et al. Keratoprosthesis with biocolonizable microporous fluorocarbon haptic. Preliminary results in a 24-patient study. Arch Ophthalmol. 1995;113(6):757–63.
Yakimenko S. Results of a PMMA/titanium keratoprosthesis in 502 eyes. Refract Corneal Surg. 1993;9:197–8.
Moroz ZI. Artificial cornea. In: Fyodorov SN, editor. Microsurgery of the eye: main aspects. Moscow: Mir; 1987.
Crawford GJ, Hicks CR, Lou X, et al. The Chirila keratoprosthesis: phase I human clinical trial. Ophthalmology. 2002;109(5):883–9.
Kim MK, Lee JL, Wee WR, et al. Seoul-type keratoprosthesis: preliminary results of the first 7 human cases. Arch Ophthalmol. 2002;120(6):761–6.
Dohlman CH, Schneider HA, Doane MG. Prosthokeratoplasty. Am J Ophthalmol. 1974;77(5):694–70.
Dorzee MJ. Kratoprothèse en acrylique. Bull Soc Belge Ophtalmol. 1955;108:582–93.
Barraquer J. Keratoplasty and keratoprosthesis. Pocklington memorial lecture (delivered at the Royal College of Surgeons of England on 5th May, 1966). Ann R Coll Surg Engl. 1967;40(2):71–81.
Doane MG, Dohlman CH, Bearse G. Fabrication of a keratoprosthesis. Cornea. 1996;15(2):179–84.
Harissi-Dagher M, Khan BF, Schaumberg DA, Dohlman CH. Importance of nutrition to corneal grafts when used as a carrier of the Boston keratoprosthesis. Cornea. 2007;26(5):564–8.
Kammerdiener LL, Speiser JL, Aquavella JV, Harissi-Dagher M, Dohlman CH, Chodosh J, Ciolino JB. Protective effect of soft contact lenses after Boston keratoprosthesis. Br J Ophthalmol. 2016;100(4):549–52.
Yaghouti F, Nouri M, Abad JC, et al. Keratoprosthesis: preoperative prognostic categories. Cornea. 2001;20:19–23.
Dohlman CH, Terada H. Keratoprosthesis in pemphigoid and Stevens – Johnson syndrome. In: Sullivan D, editor. Lacrimal gland, tear film and dry eye syndromes II. Basic science and clinical relevance. Adv Exp Med Biol. Vol. 438. New York: Plenium Publishing; 1998. p. 1021–5.
Nouri M, Terada H, Alfonso EC, et al. Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmol. 2001;119(4):484–9.
Talajic JC, Agoumi Y, Gagné S, Moussally K, Harissi-Dagher M. Prevalence, progression, and impact of glaucoma on vision after Boston type 1 keratoprosthesis surgery. Am J Ophthalmol. 2012;153(2):267–74.
Behlau I1, Martin KV, Martin JN et al. Infectious endophthalmitis in Boston keratoprosthesis: incidence and prevention. Acta Ophthalmol. 2014;92(7).
Dohlman CH, Doane MG. Some factors influencing outcome after keratoprosthesis surgery. Cornea. 1994;13(3):214–8.
Dohlman CH. Postoperative regimen and repair of complications after keratoprosthesis surgery. Refract Corneal Surg. 1993;9:198.
Dohlman CH, Dudenhoefer EJ, Khan BF, et al. Protection of the ocular surface after keratoprosthesis surgery: the role of soft contact lenses. CLAO J. 2002;28(2):72–4.
Bath PE, McCord RC, Cox KC. Nd:YAG laser discission of retroprosthetic membrane: a preliminary report. Cornea. 1983;2:225–8.
Ray S, Khan BF, Dohlman CH, et al. Management of vitreoretinal complications in eyes with permanent keratoprosthesis. Arch Ophthalmol. 2002;120(5):559–66.
Nouri M, Durand ML, Dohlman CH. Sudden reversible vitritis after keratoprosthesis: an immune phenomenon? Cornea. 2005;24(8):915–9.
Ma JJ, Graney JM, Dohlman CH. Repeat penetrating keratoplasty versus the Boston keratoprosthesis in graft failure. Int Ophthalmol Clin. 2005;45(4):49–59.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Harissi-Dagher, M. (2020). The Role of Keratoprosthesis in the Treatment of Corneal Blindness. In: Colby, K., Dana, R. (eds) Foundations of Corneal Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-25335-6_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-25335-6_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-25334-9
Online ISBN: 978-3-030-25335-6
eBook Packages: MedicineMedicine (R0)